Dr. Mitchell Katz, CEO of America's largest public hospital system, says AI could replace radiologists within 5 years, sparking debate about the future of medical imaging.
Dr. Mitchell Katz, CEO of NYC Health + Hospitals, the largest public health care system in the United States, has made waves in the medical community with his bold prediction that artificial intelligence could replace radiologists within the next five years. Speaking at a recent healthcare innovation conference, Katz outlined his vision for a future where AI systems handle the bulk of diagnostic imaging work currently performed by human specialists.
"The technology has advanced to a point where we can trust AI to read and interpret medical images with accuracy that matches or exceeds human radiologists," Katz stated. "In our public health system, which serves over 1 million patients annually across 11 hospitals, we're already piloting AI-assisted diagnostic tools that show tremendous promise."

The statement has ignited fierce debate among healthcare professionals. While some see AI as a tool to augment radiologist capabilities and address staffing shortages, others view Katz's prediction as premature and potentially dangerous.
Dr. Sarah Chen, a radiologist at Mount Sinai Hospital, responded critically to the announcement. "Radiology is far more complex than pattern recognition. We're not just reading images - we're considering patient history, correlating findings with other tests, consulting with referring physicians, and making nuanced clinical judgments. AI can be a powerful assistant, but replacing the human element entirely is a significant leap."
Katz's comments come amid growing investment in medical AI. Companies like Aidoc, Zebra Medical Vision, and Google's DeepMind have developed AI systems that can detect conditions ranging from lung cancer to brain hemorrhages with impressive accuracy. The global AI in medical imaging market is projected to reach $2 billion by 2025, growing at a compound annual rate of over 30%.
However, regulatory and ethical hurdles remain substantial. The FDA has approved several AI diagnostic tools, but they typically function as "second readers" that flag potential issues for human review rather than making autonomous decisions. Questions about liability in cases of AI misdiagnosis, data privacy concerns, and the need for diverse training datasets to prevent bias all pose significant challenges to widespread adoption.
For NYC Health + Hospitals, the financial pressures of serving a predominantly low-income patient population add another dimension to the AI discussion. Katz argues that AI could help address the system's radiologist shortage while reducing costs. "We have facilities where a single radiologist might be responsible for reading hundreds of scans per day. AI could help distribute that workload more effectively and ensure no patient falls through the cracks," he explained.
The American College of Radiology has taken a more measured stance, emphasizing that AI should be viewed as a tool to enhance radiologist productivity rather than replace them. "The future of radiology will likely involve human-AI collaboration, where each plays to their strengths," said Dr. Keith Dreyer, Vice Chairman of Radiology at Massachusetts General Hospital.
As the debate continues, one thing is clear: AI is already transforming medical imaging, even if complete replacement of radiologists remains a contentious prospect. For now, the technology appears poised to handle routine screening tasks while more complex cases still require human expertise. Whether that balance shifts dramatically in the next five years, as Katz predicts, will depend on technological advances, regulatory decisions, and perhaps most importantly, the medical community's willingness to embrace such a fundamental change to their profession.

For patients of NYC Health + Hospitals and similar public systems across the country, the outcome of this debate could significantly impact their healthcare experience - potentially improving access to diagnostic services while raising questions about the role of human judgment in critical medical decisions.

Comments
Please log in or register to join the discussion